Table 1.
Treatment Schema
Group1 | Group2 | Group3 | |
---|---|---|---|
Melphalan | 100 mg/m2 IV Days −4, −3 |
100 mg/m2 IV Days −4, −3 |
100 mg/m2 IV Days −4, −3 |
Ascorbic Acid | 1000 mg IV Days −9 to −3 |
1000 mg IV Days −9 to −3 |
1000 mg IV Days −9 to −3 |
Arsenic Trioxide | 0.25 mg/kg Days −9 to −3 |
0.25 mg/kg Days −9 to −3 |
0.25 mg/kg Days −9 to −3 |
Bortezomib | None | 1 mg/m2 Days −9, −6, −3 |
1.5 mg/m2 Days −9, −6, −3 |